Tiger Brokers

INSILICO expands share capital by 0.53% through option exercises and award vesting

Bulletin Express
Jul 06

InSilico Medicine Cayman TopCo (INSILICO, HKEx: 03696) reported a 0.53% increase in its issued share capital following the allotment of 3.05 million new ordinary shares between 2 July and 6 July 2026.

Key data

• Opening share count (30 Jun 2026): 575.84 million shares.

• New shares issued under Pre-IPO Equity Incentive Plans:  – 02 Jul: 0.76 million shares at HKD 6.3493 each (non-director option exercise).  – 03 Jul: 0.29 million shares at HKD 7.9331 each (non-director option exercise).  – 06 Jul: 0.40 million shares at HKD 9.9163 each (non-director option exercise).  – 06 Jul: 1.60 million shares at nil consideration (director share-award vesting).

• Closing share count (06 Jul 2026): 578.89 million shares.

No treasury shares were held, repurchased, or cancelled during the period, and the board confirmed full compliance with Hong Kong listing and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10